MedPath

Analysis for localization of epileptogenic zone of intracranial EEG in patients with drug resistant epilepsy

Not Applicable
Recruiting
Conditions
Diseases of the nervous system
Registration Number
KCT0005983
Lead Sponsor
Samsung Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
126
Inclusion Criteria

[Prospective intervention group]
(1) Patients diagnosed with local epilepsy
(2) Men and women aged 4 or older and younger than 70 years old
(3) Patients who need epilepsy surgery due to drug refractory
(4) Patients who need intracranial electrode insertion and intracranial EEG examination for localization of epilepsy focus
(5) Those who agreed to participate in the study

[Historical control]
(1) Patients diagnosed with drug refractory local epilepsy
(2) Men and women aged 4 years or older and younger than 70 years old
(3) Patients who had an intracranial electrode inserted for epilepsy surgery before the start of the study, recorded intracranial EEG, and received resection surgery without HFO test

Exclusion Criteria

(1) If you do not want to participate in the study
(2) Patients with drug-refractory epilepsy who do not require intracranial electrode insertion

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Surgical outcome (seizure-free vs. seizure-persistent groups)
Secondary Outcome Measures
NameTimeMethod
HFO resection rate
© Copyright 2025. All Rights Reserved by MedPath